BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 19, 1999, Pages 10824-10829

  Chabrier, Pierre Etienne ^a   Auguet, Michel ^a   Spinnewyn, Brigitte ^a   Auvin, Serge ^a   Cornet, Sylvie ^a   Demerlé Pallardy, Caroline ^a   Guilmard Favre, Christine ^a   Marin, Jean Grégoire ^a   Pignol, Bernadette ^a   Gillard Roubert, Véronique ^a   Roussillot Charnet, Christelle ^a   Schulz, Jocelyne ^a   Viossat, Isabelle ^a   Bigg, Dennis ^a   Moncada, Salvador ^b  

^a Institut Henri Beaufour   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; N [4 [4 [(3,4 DIHYDRO 6 HYDROXY 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 2 YL)CARBONYL] 1 PIPERAZINYL]PHENYL] 2 THIOPHENECARBOXIMIDAMIDE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; BRAIN INJURIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GERBILLINAE; INHIBITORY CONCENTRATION 50; KINETICS; LIPID PEROXIDATION; MALE; MICE; MYOCARDIAL ISCHEMIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; ORGAN CULTURE TECHNIQUES; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES; TIME FACTORS;

ANIMALIA; GERBILLINAE;

EID: 13044295425     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.19.10824     Document Type: Article

References (40)

1. Dyker, A. G. & Lees, K. R. (1998) Stroke 29, 535-542.
2. Parsons, C. G., Danysz, W. & Quack, G. (1998) Drug News Perspect. 11, 523-569.
3. Hickenbottom, S. L. & Grotta, J. (1998) Semin. Neurol. 18, 485-492.
4. del Zoppo, G. J. (1998) Neurology 51, S59-S61.
5. Spinnewyn, B., Cornet, S., Auguet, M. & Chabrier, P.-E. (1999) J. Cereb. Blood Flow Metab. 19, 139-143.
6. Hall, E. D. (1989) Crit. Care Clin. 5, 793-805.
7. Malinski, T., Bailey, F., Zhang, Z. G. & Chopp, M. (1993) J. Cereb. Blood Flow Metab. 13, 355-358.
8. Kumura, E., Yoshimine, T., Kubo, S., Tanaka, S., Hayakawa, T., Shiga, T. & Kosaka, H. (1995) Neurosci. Lett. 200, 137-140.
9. Chan, P. H. (1996) Stroke 27, 1124-1129.
10. Iadecola, C. (1997) Trends. Neurosci. 20, 132-139.
11. Samdani, A. F., Dawson, T. M. & Dawson, V. L. (1997) Stroke 28, 1283-1288.
12. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B. A. (1990) Proc. Natl. Acad. Sci. USA 87, 1620-1624.
13. Garthwaite, J., Charles, S. L. & Chess-Williams, R. (1988) Nature (London) 336, 385-388.
14. Copin, J. C., Ledig, M. & Tholey, G. (1992) Neurochem. Res. 17, 677-682.
15. Lafon-Cazal, M., Pietri, S., Culcasi, M. & Bockaert, J. (1993) Nature (London) 364, 535-537.
16. Matsuo, Y., Kihara, T., Ikeda, M., Ninomiya, M., Onodera, H. & Kogure, K. (1995) J. Cereb. Blood Flow Metab. 15, 941-947.
17. Bredt, D. S. & Snyder, S. H. (1989) Proc. Natl. Acad. Sci. USA 86, 9030-9033.
18. Guilmard, C., Auguet, M. & Chabrier, P.-E. (1998) Nitric Oxide 2, 147-154.
19. Esterbauer, H. & Cheeseman, K. H. (1990) Methods Enzymol. 186, 407-421.
20. Lolic, M. M., Fiskum, G. & Rosenthal, R. E. (1997) Ann. Emerg. Med. 29, 758-765.
21. Domingo, M. T., Spinnewyn, B., Chabrier, P.-E. & Braquet, P. (1994) Brain Res. 640, 268-276.
22. Hall, E. D. (1985) J. Neurosurg. 62, 882-887.
23. Callaway, J. K., Beart, P. M. & Jarrott, B. (1998) J. Pharmacol. Toxicol. Methods 39, 155-162.
24. Hall, E. D. & Braughler, J. M. (1989) Free Radic. Biol. Med. 6, 303-313.
25. Siesjo, B. K., Agardh, C. D. & Bengtsson, F. (1989) Cerebrovasc. Brain Metab. Rev. 1, 165-211.
26. Moncada, S., Palmer, R. M. & Higgs, E. A. (1991) Pharmacol. Rev. 43, 109-142.
27. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C. & Moskowitz, M. A. (1994) Science 265, 1883-1885.
28. Huang, Z., Huang, P. L., Ma, J., Meng, W., Ayata, C., Fishman, M. C. & Moskowitz, M. A. (1996) J. Cereb. Blood Flow Metab. 16, 981-987.
29. Zhang, Z. G., Reif, D., Macdonald, J., Tang, W. X., Kamp, D. K., Gentile, R. J., Shakespeare, W. C., Murray, R. J. & Chopp, M. (1996) J. Cereb. Blood Flow Metab. 16, 599-604.
30. O'Neill, M. J., Hicks, C. & Ward, M. (1996) Eur. J. Pharmacol. 310, 115-122.
31. Escott, K. J., Beech, J. S., Haga, K. K., Williams, S. C., Meldrum, B. S. & Bath, P. M. (1998) J. Cereb. Blood Flow Metab. 18, 281-287.
32. Nagafuji, T., Sugiyama, M., Matsui, T. & Koide, T. (1993) Eur. J. Pharmacol. 248, 325-328.
33. Carreau, A., Duval, D., Poignet, H., Scatton, B., Vige, X. & Nowicki, J. P. (1994) Eur. J. Pharmacol. 256, 241-249.
34. Kuroda, S. & Siesjo, B. K. (1997) Clin. Neurosci. 4, 199-212.
35. Wahl, F., Allix, M., Plotkine, M. & Boulu, R. G. (1992) Stroke 23, 267-272.
36. Yamaguchi, T., Suzuki, M. & Yamamoto, M. (1995) Brain Res. 669, 107-114.
37. Aronowski, J., Strong, R. & Grotta, J. C. (1996) Stroke 27, 1571-1576.
38. Zhang, R. L., Zhang, Z. G. & Chopp, M. (1999) Neurology 52, 273-279.
39. Ma, J., Endres, M. & Moskowitz, M. A. (1998) Br. J. Pharmacol. 124, 756-762.
40. Jiang, Q., Chopp, M., Zhang, Z. G., Helpern, J. A., Ordidge, R. J., Ewing, J., Jiang, P. & Marchese, B. A. (1994) J. Cereb. Blood Flow Metab. 14, 732-741.